SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-062814
Filing Date
2023-05-19
Accepted
2023-05-19 20:07:32
Documents
1
Period of Report
2023-05-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2316383-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2316383-3_4seq1.xml 4 4012
  Complete submission text file 0001104659-23-062814.txt   5411
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Issuer) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRANSCODE THERAPEUTICS, INC. 6 LIBERTY SQUARE, #2382 BOSTON MA 02109
Business Address
Fitzgerald Thomas A (Reporting) CIK: 0001854168 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40363 | Film No.: 23942135